[18F]-TZ-Z-09591

N/A

Report date: 2025/11/21 17:16:40

Base Information

Drug Name[18F]-TZ-Z-09591
Drug Alias Name[18F]-TZ-Z-09591[18F]TZ-Z09591
ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionPlatelet-derived growth factor receptor beta modulators
TargetsPlatelet-derived growth factor receptor beta
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffibody Medical AB
China Registration ClassN/A

Develop Information

Active CompaniesAffibody Medical ABUppsala University
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A